A retrospective review sought to better understand the relationship between bortezomib and lenalidomide therapy and treatment-induced skin rash in multiple myeloma.
Although social determinants of health (SDOH) components affect patients with cancer, nurses tended not to consider them when speaking with patients or making recommendations about physical activity. These findings were published in the Clinical Journal of Oncology Nursing. Among staff in the healthcare setting, nurses make unique bonds with patients, often having sensitive and personal…
A retrospective analysis of data identified predictors of cardiac adverse events in patients with CML undergoing treatment with tyrosine kinase inhibitors.
A data analysis of electronic health records of pediatric cancer survivors revealed higher risk of CVD and mortality, and a lack of follow-up guideline adherence.
Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.
Researchers conducted semi-structured interviews with patients with multiple myeloma to determine what factors influence their ability to participate in shared decision making with their clinicians.
As myeloproliferative neoplasms (MPN) are a particularly rare form of blood cancer without a clear cause, it may be difficult to understand how lifestyle factors can affect both MPN risk and symptom burden. What has research suggested about the ways certain lifestyle factors affect MPNs?
Very severe immune-related adverse events on immune checkpoint inhibitor therapy occur earlier than less severe ones appear to and may have predictors.
Multivariate analysis of patients with MPNs receiving antiplatelet or anticoagulation therapy revealed an increase in risk of bleeding events in these patients.
A new study suggests apixaban may be a potential treatment for cancer-associated venous thromboembolism, with possible variation in outcomes by cancer site.
A new study projects that increasing HPV vaccination rates will trend toward reduced incidence of oropharyngeal cancer among younger adults until 2045.
Researchers sought to determine whether palliative care was different for patients with hematological malignancies than for those with other malignancies.
